459 related articles for article (PubMed ID: 31261380)
21. The GABAergic septohippocampal connection is impaired in a mouse model of tauopathy.
Soler H; Dorca-Arévalo J; González M; Rubio SE; Ávila J; Soriano E; Pascual M
Neurobiol Aging; 2017 Jan; 49():40-51. PubMed ID: 27743524
[TBL] [Abstract][Full Text] [Related]
22. Adult-onset focal expression of mutated human tau in the hippocampus impairs spatial working memory of rats.
Mustroph ML; King MA; Klein RL; Ramirez JJ
Behav Brain Res; 2012 Jul; 233(1):141-8. PubMed ID: 22561128
[TBL] [Abstract][Full Text] [Related]
23. GFP-Mutant Human Tau Transgenic Mice Develop Tauopathy Following CNS Injections of Alzheimer's Brain-Derived Pathological Tau or Synthetic Mutant Human Tau Fibrils.
Gibbons GS; Banks RA; Kim B; Xu H; Changolkar L; Leight SN; Riddle DM; Li C; Gathagan RJ; Brown HJ; Zhang B; Trojanowski JQ; Lee VM
J Neurosci; 2017 Nov; 37(47):11485-11494. PubMed ID: 28986461
[TBL] [Abstract][Full Text] [Related]
24. Fyn depletion ameliorates tau
Liu G; Fiock KL; Levites Y; Golde TE; Hefti MM; Lee G
Acta Neuropathol Commun; 2020 Jul; 8(1):108. PubMed ID: 32665013
[TBL] [Abstract][Full Text] [Related]
25. CNS cell type-specific gene profiling of P301S tau transgenic mice identifies genes dysregulated by progressive tau accumulation.
Ke YD; Chan G; Stefanoska K; Au C; Bi M; Müller J; Przybyla M; Feiten A; Prikas E; Halliday GM; Piguet O; Kiernan MC; Kassiou M; Hodges JR; Loy CT; Mattick JS; Ittner A; Kril JJ; Sutherland GT; Ittner LM
J Biol Chem; 2019 Sep; 294(38):14149-14162. PubMed ID: 31366728
[TBL] [Abstract][Full Text] [Related]
26. Cornel Iridoid Glycoside Suppresses Hyperactivity Phenotype in rTg4510 Mice through Reducing Tau Pathology and Improving Synaptic Dysfunction.
Ma DL; Luo Y; Huang R; Zhao ZR; Zhang L; Li YL; Wang Q; Li L; Zhang L
Curr Med Sci; 2020 Dec; 40(6):1031-1039. PubMed ID: 33428130
[TBL] [Abstract][Full Text] [Related]
27. Picalm reduction exacerbates tau pathology in a murine tauopathy model.
Ando K; De Decker R; Vergara C; Yilmaz Z; Mansour S; Suain V; Sleegers K; de Fisenne MA; Houben S; Potier MC; Duyckaerts C; Watanabe T; Buée L; Leroy K; Brion JP
Acta Neuropathol; 2020 Apr; 139(4):773-789. PubMed ID: 31925534
[TBL] [Abstract][Full Text] [Related]
28. Interneuronal transfer of human tau between Lamprey central neurons in situ.
Kim W; Lee S; Jung C; Ahmed A; Lee G; Hall GF
J Alzheimers Dis; 2010; 19(2):647-64. PubMed ID: 20110609
[TBL] [Abstract][Full Text] [Related]
29. Filamin-A and Myosin VI colocalize with fibrillary Tau protein in Alzheimer's disease and FTDP-17 brains.
Feuillette S; Deramecourt V; Laquerriere A; Duyckaerts C; Delisle MB; Maurage CA; Blum D; Buée L; Frébourg T; Campion D; Lecourtois M
Brain Res; 2010 Jul; 1345():182-9. PubMed ID: 20460118
[TBL] [Abstract][Full Text] [Related]
30. Age-dependent axonal transport and locomotor changes and tau hypophosphorylation in a "P301L" tau knockin mouse.
Gilley J; Seereeram A; Ando K; Mosely S; Andrews S; Kerschensteiner M; Misgeld T; Brion JP; Anderton B; Hanger DP; Coleman MP
Neurobiol Aging; 2012 Mar; 33(3):621.e1-621.e15. PubMed ID: 21492964
[TBL] [Abstract][Full Text] [Related]
31. Regenerating islet-derived 1α (REG-1α) protein increases tau phosphorylation in cell and animal models of tauopathies.
Moussaed M; Huc-Brandt S; Cubedo N; Silhol M; Murat S; Lebart MC; Kovacs G; Verdier JM; Trousse F; Rossel M; Marcilhac A
Neurobiol Dis; 2018 Nov; 119():136-148. PubMed ID: 30092268
[TBL] [Abstract][Full Text] [Related]
32. Mutant Tau knock-in mice display frontotemporal dementia relevant behaviour and histopathology.
Koss DJ; Robinson L; Drever BD; Plucińska K; Stoppelkamp S; Veselcic P; Riedel G; Platt B
Neurobiol Dis; 2016 Jul; 91():105-23. PubMed ID: 26949217
[TBL] [Abstract][Full Text] [Related]
33. Tau-mediated nuclear depletion and cytoplasmic accumulation of SFPQ in Alzheimer's and Pick's disease.
Ke YD; Dramiga J; Schütz U; Kril JJ; Ittner LM; Schröder H; Götz J
PLoS One; 2012; 7(4):e35678. PubMed ID: 22558197
[TBL] [Abstract][Full Text] [Related]
34. Early depletion of CA1 neurons and late neurodegeneration in a mouse tauopathy model.
Helboe L; Egebjerg J; Barkholt P; Volbracht C
Brain Res; 2017 Jun; 1665():22-35. PubMed ID: 28411086
[TBL] [Abstract][Full Text] [Related]
35. Developmental Pathogenicity of 4-Repeat Human Tau Is Lost with the P301L Mutation in Genetically Matched Tau-Transgenic Mice.
Gamache JE; Kemper L; Steuer E; Leinonen-Wright K; Choquette JM; Hlynialuk C; Benzow K; Vossel KA; Xia W; Koob MD; Ashe KH
J Neurosci; 2020 Jan; 40(1):220-236. PubMed ID: 31685653
[TBL] [Abstract][Full Text] [Related]
36. High copy wildtype human 1N4R tau expression promotes early pathological tauopathy accompanied by cognitive deficits without progressive neurofibrillary degeneration.
Wheeler JM; McMillan PJ; Hawk M; Iba M; Robinson L; Xu GJ; Dombroski BA; Jeong D; Dichter MA; Juul H; Loomis E; Raskind M; Leverenz JB; Trojanowski JQ; Lee VM; Schellenberg GD; Kraemer BC
Acta Neuropathol Commun; 2015 Jun; 3():33. PubMed ID: 26041339
[TBL] [Abstract][Full Text] [Related]
37. Hyperactivity with Agitative-Like Behavior in a Mouse Tauopathy Model.
Jul P; Volbracht C; de Jong IE; Helboe L; Elvang AB; Pedersen JT
J Alzheimers Dis; 2016; 49(3):783-95. PubMed ID: 26519432
[TBL] [Abstract][Full Text] [Related]
38. Neuroprotective effects of Cerebrolysin in triple repeat Tau transgenic model of Pick's disease and fronto-temporal tauopathies.
Rockenstein E; Ubhi K; Mante M; Florio J; Adame A; Winter S; Brandstaetter H; Meier D; Masliah E
BMC Neurosci; 2015 Nov; 16():85. PubMed ID: 26611895
[TBL] [Abstract][Full Text] [Related]
39. Zinc Exacerbates Tau Pathology in a Tau Mouse Model.
Craven KM; Kochen WR; Hernandez CM; Flinn JM
J Alzheimers Dis; 2018; 64(2):617-630. PubMed ID: 29914030
[TBL] [Abstract][Full Text] [Related]
40. The direct role of 5-lipoxygenase on tau pathology, synaptic integrity and cognition in a mouse model of tauopathy.
Vagnozzi AN; Giannopoulos PF; Praticò D
Transl Psychiatry; 2017 Dec; 7(12):1288. PubMed ID: 29249809
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
